Bio-XCell coming along nicely
- RM100mil earmarked from government to run operations for 2013
- Pipeline of 12 businesses eager to spend money on usa’s first committed biotech park
THERE has been constant help from the Government for Malaysia’s biotech objectives which might be targeted on the 15-yr National Biotechnology Policy (NBP) launched in April, 2005.
The modern day indication of assist is the RM100 million (US$33 million) earmarked for Bio-XCell, the u . S . A .’s first devoted biotechnology commercial enterprise park inside the Iskandar development hub within the southern kingdom of Johor.
This is on top of the RM100 million kick-off investment it acquired at its release in 2010, which become for a period of years. Bio-XCell is 60% owned with the aid of Biotechnology Corporation and forty% by using UEM Land Bhd.
The more potent investment aid is needed as the NBP has moved from the potential- constructing cognizance of Phase 1 to the Science-to-Business Phase 2 which makes a speciality of the enterprise components, which include developing know-how in drug discovery and development based totally on herbal assets; encouraging new product improvement; and pushing for era acquisition and licensing.
Bio-XCell is seen as a key enabler for Phase 2. As its call indicates, the park is custom-constructed to help accelerate the targets of biotech businesses that desire to base themselves in a supportive ecosystem with conveniently to be had expertise, resources and complementary players.
The key regions that Bio-XCell is focusing on are business and healthcare biotechnology and R&D.
Bio-XCell itself is a one-stop employer that targets to promote the improvement of a supportive biotechnology surroundings round strategic anchor tenants. The activity of ensuring the pieces falls into location lie with Rizatuddin Ramli (p.c), its leader executive officer.
With the raise of India’s biggest biotechnology organisation, Biocon, as its anchor tenant with a complete RM1.972 billion (US$644 million) funding for its insulin facility, Rizatuddin says the team at Bio-XCell has been operating difficult at building a base of tenants at the park a good way to be complementary to every different’s needs, besides being interested in the offerings and incentives at Bio-XCell.
“We have already got 12 companies in our pipeline, 3 huge ones which can be keen on taking over quite enormous land for their plans, and 9 medium sized to smaller organizations interested by the four shells that we've built,” he says, declining to percentage any names until the deals are signed.
The 4 investments which can be recognized include two healthcare biotech businesses and two business biotech groups.
Aside from Biocon, within the healthcare area is Agila Biotech, a subsidiary of India's Strides Arcolab a good way to produce biotherapeutic merchandise and carry out agreement manufacturing as properly. The industrial biotech companies contain METabolic EXplorer from France, so that you can be the primary inside the global to supply 1:3 Propanediol from crude glycerine; and US-based Glycos Biotechnologies, as a way to produce isoprene, utilized in artificial rubber, with an preliminary funding of US$14 million.
According to Rizatuddin, Bio-XCell is focused on agencies that are typically seeking out three matters: Ready-made infrastructure and facilities; a talent pool; and the tenant mix of the biotech park.
The latter is due to the fact businesses want to be in a synergistic cluster in which they also can use each other’s products and services to maintain charges down and maximize assets. In that experience, this isn't always unlike the manner tech companies and suppliers cluster collectively.
At the equal time, he is also enthusiastic about the October signing of a S$1.five billion joint project among Ascendas Land International of Singapore and UEM Land to develop a era park in Iskandar Malaysia.
The 210ha tech park may be positioned in Nusajaya and offer satisfactory infrastructure to aid quite a number industries including electronics, pharmaceutical and scientific devices, meals processing, precision engineering, rapid-moving consumer items, logistics and warehousing and standard engineering services.
“I assume we can paintings collectively in a synergistic cluster,” he says of that development.
Among the offerings Bio-XCell is offering to its tenants this is “synergistic” with their wishes is the Standard Shell Scheme (Shells) which essentially presents tenants with a simply available plant in a standardized layout which “essentially lets in tenants the power to move right in and renovate or healthy-out the distance in line with their operational needs,” says Rizatuddin.
The concept is that a few tenants might also want to transport in proper away while watching for their fundamental facility to be equipped, and the Shells provide a handy meantime vicinity.
For instance, Biocon’s biomanufacturing facility will only see complete production in 2016 however it has its present manufacturing base in India to depend upon inside the meantime. Other companies will probably no longer have the sources of Biocon and hence the enchantment of the four Shells supplied.
The Shells include a constructed-up region of round 20,000 squarefeet. Each prices RM4.5 million to RM5 million to construct and at RM3.10 in keeping with squareft, may be leased at a month-to-month charge of RM62,000.
[RM1 = US$0.33]
Long-term lease of up to three years is available and with a primary-come first-served basis, the 9 corporations are racing amongst themselves to decide who receives the 4 Shells.
“But if there may be call for for extra, we can construct some more,” says Rizatuddin. The Shells are also on the market at between RM7 million to RM8 million.
The Shells are not stand-alones although and are available complemented through the RM44.7-million Central Hub. To be geared up by way of 0.33 zone of 2013, the Central Hub is anticipated to function the focus within the Bio-XCell biotechnology park, acting as a catalyst for biotechnology ecosystem in Iskandar Malaysia.
The multi-purpose complex, comprising a business constructing, a technology building and an auditorium, affords a collaborative environment for the biotech community Bio-XCell is constructing.
Companies can have get right of entry to to serviced office suites, excessive-velocity broadband, a commercial enterprise center, business front room, meeting rooms, and 20,000 squaretoes of lab spaces to accelerate their business operations and technological traits. It is designed with elements of a green building.
Beyond the facilities and offerings presented, 3 technology systems will offer tenants cost-delivered services. These come from 3 companies that BiotechCorp had obtained/ licensed which tenants at Bio-XCell will revel in at nominal fee:
- Manufacturing of Nanoparticles, supplied through French organisation Nanobiotix SA;
- Microarray, supplied via Australian organisation Medsaic Pty Ltd; and
- Supercritical Fluid Extraction (SFE) and Particle Formation, advanced with the aid of FeyeCon Development and Implementation BV from the Netherlands.
Once Bio-XCell is absolutely operational, it'll create 3,000 process possibilities inside the next five years. Cognizant of the contemporary talent shortfall in this space, Rizatuddin says that apart from the diverse ongoing applications to build a biotech expertise pool, round 20% of foreign skills might be engaged to support the industry.
Related Stories:
Bio-XCell taking shape in Iskandar
Biocon India’s chairman bullish on Malaysia’s biotech possibilities
For greater generation news and the modern day updates, follow @dnewsasia on Twitter or Like us on Facebook.